The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...
The planned $4 billion cut in funding for scientific inquiry to the nation’s universities and academic medical institutions ...
Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.
The Department of Health and Human Services (HHS) canceled more than $180 million in contracts over 48 hours, including a ...
Eating gradually increasing doses of store-bought, home-measured peanut butter for about 18 months enabled 100% of children with peanut allergy who initially could tolerate the equivalent of at least ...
NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.
Children with high-threshold peanut allergies showed incredible improvements after undergoing an 18-month program using store ...
Children with high-threshold peanut allergy who ate gradually larger doses of store-bought peanut butter achieved ...